Act Now
Sign A Message of Support
The ACLU and the Public Patent Foundation (PUBPAT) are bringing a landmark case on behalf of researchers, pathologists, breast cancer and women’s health groups, and individual women affected by the patents on two genes associated with breast and ovarian cancer. It's wrong for companies to own the rights to pieces of the human genome.
Related Multimedia
Advancing Gender Equality
“Advancing Gender Equality: The Impact of CEDAW Ratification on Women’s Rights in the U.S.” Parallel Event at the UN Commission on the Status of Women March ...
